SG48892A1 - Chimeric L- and P-selectin by exchange of domains-uses thereof - Google Patents

Chimeric L- and P-selectin by exchange of domains-uses thereof

Info

Publication number
SG48892A1
SG48892A1 SG1996003546A SG1996003546A SG48892A1 SG 48892 A1 SG48892 A1 SG 48892A1 SG 1996003546 A SG1996003546 A SG 1996003546A SG 1996003546 A SG1996003546 A SG 1996003546A SG 48892 A1 SG48892 A1 SG 48892A1
Authority
SG
Singapore
Prior art keywords
polypeptides
domains
lectin
chimeric
peptides
Prior art date
Application number
SG1996003546A
Other languages
English (en)
Inventor
Thomas F Tedder
Geoffrey S Kansas
Original Assignee
Dana Faber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Faber Cancer Inst Inc filed Critical Dana Faber Cancer Inst Inc
Publication of SG48892A1 publication Critical patent/SG48892A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
SG1996003546A 1993-01-25 1994-01-25 Chimeric L- and P-selectin by exchange of domains-uses thereof SG48892A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US845993A 1993-01-25 1993-01-25

Publications (1)

Publication Number Publication Date
SG48892A1 true SG48892A1 (en) 1998-05-18

Family

ID=21731721

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996003546A SG48892A1 (en) 1993-01-25 1994-01-25 Chimeric L- and P-selectin by exchange of domains-uses thereof

Country Status (14)

Country Link
US (2) US5808025A (ja)
EP (1) EP0689599B1 (ja)
JP (1) JPH08506017A (ja)
AT (1) ATE174344T1 (ja)
AU (1) AU694933B2 (ja)
CA (1) CA2153802A1 (ja)
DE (1) DE69415154T2 (ja)
DK (1) DK0689599T3 (ja)
ES (1) ES2126742T3 (ja)
GR (1) GR3029640T3 (ja)
HK (1) HK1011382A1 (ja)
NZ (1) NZ261991A (ja)
SG (1) SG48892A1 (ja)
WO (1) WO1994017193A2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648458A (en) * 1992-05-06 1997-07-15 Affymax Technologies N.V. Peptides and compounds that bind to ELAM-1
US5728802A (en) * 1992-05-06 1998-03-17 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
US5643873A (en) * 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US20020040008A1 (en) * 1995-01-24 2002-04-04 Wagner Denisa D. Method for treating and preventing atherosclerosis
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7169376B2 (en) * 2004-06-10 2007-01-30 Chevron U.S.A. Inc. Method for making hydrogen using a gold containing water-gas shift catalyst
MY148646A (en) * 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
AR048840A1 (es) * 2004-05-11 2006-05-31 Boehringer Ingelheim Int Epitopes inductores de la muerte de las celulas t
CA2838952C (en) 2011-06-13 2020-11-24 Stefan Bassarab Anti-psgl-1 antibodies and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
US5081034A (en) * 1988-11-14 1992-01-14 Brigham & Women's Hospital Cloned genes which encode elam-1
US5098833A (en) * 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor
US5216131A (en) * 1989-02-23 1993-06-01 Genentech, Inc. Lymphocyte homing receptors
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5026537A (en) * 1989-04-06 1991-06-25 Centocor, Inc. Methods for imaging atherosclerotic plaque
WO1991007993A1 (en) * 1989-11-30 1991-06-13 Mathew Vadas Anti-inflammatory and anti-adhesive factors
US5709859A (en) * 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
AU2006792A (en) * 1991-05-15 1992-12-30 Dana-Farber Cancer Institute, Inc. Leukocyte-associated cell surface protein

Also Published As

Publication number Publication date
NZ261991A (en) 1998-04-27
CA2153802A1 (en) 1994-08-04
US5834425A (en) 1998-11-10
WO1994017193A3 (en) 1994-11-10
DE69415154T2 (de) 1999-07-29
EP0689599B1 (en) 1998-12-09
JPH08506017A (ja) 1996-07-02
ES2126742T3 (es) 1999-04-01
HK1011382A1 (en) 1999-07-09
GR3029640T3 (en) 1999-06-30
EP0689599A1 (en) 1996-01-03
ATE174344T1 (de) 1998-12-15
AU694933B2 (en) 1998-08-06
US5808025A (en) 1998-09-15
AU6128494A (en) 1994-08-15
WO1994017193A2 (en) 1994-08-04
DK0689599T3 (da) 1999-08-16
DE69415154D1 (de) 1999-01-21

Similar Documents

Publication Publication Date Title
WO1997021993A3 (en) Nuclear receptor ligands and ligand binding domains
SG48892A1 (en) Chimeric L- and P-selectin by exchange of domains-uses thereof
WO1999026966A3 (en) Nuclear receptor ligands and ligand binding domains
GR3031720T3 (en) Monoclonal antibodies against receptor-induced binding sites.
IL133972A (en) A fusion protein between the soluble receptor and il-6 and the ligand, its analogs and their uses
BR0314092A (pt) proteìnas de fusão de transferrina modificadas
EP0991618A4 (en) SELECTIVE ANALOGS OF THYROID HORMONES
CA2100559A1 (en) Domains of extracellular region of human platelet derived growth factor receptor polypeptides
IL160289A0 (en) Modified transferrin fusion proteins
GR3034352T3 (en) Novel polypeptides for promoting cell attachment.
IL114668A0 (en) Htk ligand
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
EP0185076A4 (ja)
EP0441483A3 (en) Expression vectors that produce steroid receptors, steroid receptor chimera, screening assays for steroid receptors and clinical assays using synthesized receptors and receptor vectors
AU7657387A (en) Apoprotein b-100 specific monoclonal antibodies
DE3268740D1 (en) Rapid, quantitative peptide synthesis using mixed anhydrides
AU4157501A (en) Her-2 binding antagonists
IN172885B (ja)
IL90997A0 (en) Irreversible peptide ligands for bombesin receptors,their preparation and pharmaceutical compositions containing them
WO1992016623A3 (en) Receptors for bombesin-like peptides
GR1002145B (en) Monoclonal antibodies against receptor - induced binding sites
ATE28450T1 (de) (alkylsulfonyl)methansulfonate als antikrebsmittel.
IL133972A0 (en) Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
EA200400384A1 (ru) Растворимый рецептор т-клетки
WO2001042294A3 (en) Clasp-4 transmembrane protein